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ABSTRACT: The present work was focused on the development and characterization of new hydrogel systems based on natural
origin polymers, namely, alginate and carrageenan, into different formats and with adequate properties to sustain the viability of
encapsulated cells, envisioning their application as cell delivery vehicles for tissue regeneration. Different formulations of alginate
and carrageenan hydrogels and different processing parameters were considered to determine the best conditions required to
achieve the most adequate response in terms of the mechanical stability, cell viability, and functionality of the developed systems.
The morphology, size, and structure of the hydrogels and their degradation behavior and mechanical properties were evaluated
during this study. In addition to cytotoxicity studies, preliminary experiments were carried out to investigate the ability of
alginate−carrageenan beads/fibers to encapsulate chondrocytes. The results obtained indicated that the different formulations,
both in the form of beads and fibers, have considerable potential as cell-carrier materials for cell delivery in tissue engineering/
regenerative medicine applications.
■ INTRODUCTION
Hydrogels are the basis for cell encapsulation/delivery systems,
one of the most promising approaches for the delivery of cells
and therapeutic agents to the site of interest, allowing a wide
range of application in the regenerative medicine field.1 During
the past decade, several different hydrogels, particularly algal
polysaccharides, have been used as cell-delivery matrices.2,3
Naturally derived hydrogels have frequently been employed
because they are either composed of components or have
macromolecular properties similar to the natural extracellular
matrix of human tissues.4,5 With today’s interest in novel
renewable polymers, the underexploited marine red algae family
belonging to carrageenan seaweeds stimulated our interest as a
source of polysaccharides with innovative structure and
functional properties. Many different hydrogels have been
previously studied for biomedical applications, but carrageenan
displays a unique potential in this field and has been very little
explored until the present time. Carrageenan is a naturally
occurring polysaccharide used far more widely than agar as
emulsifier, gelling, thickening and stabilizing agent in
pharmaceutical6 and industrial formulations. Their relatively
low cost promoted their use in environmental and commercial
applications as well.7 This hydrophilic polysaccharides resemble
to some extent the naturally occurring glycosaminoglycans
(GAGs) owing to their backbone composition of sulphated
disaccharides.8 There are three main commercial classes of
carrageenan, namely, kappa, which has only one negative
charge per disaccharide and produces strong, rigid gels
(extracted from Kappaphycus cottonii), the ι-type, which has
intermediate sulfate content and produces soft gels that provide
excellent freeze/thaw stability (extracted from Eucheuma
spinosum), and λ, which is highly sulphated, less likely to
form a gel structure, but forming gels when mixed with proteins
rather than water.9 Potassium salts are essential for κ-
carrageenan hydrogel in order to form this firm gel structure.
As the level of potassium is increased, the resulting gel structure
becomes tightly aggregated and may cause syneresis (moisture
on the gel surface; the separation of liquid from a gel).10 ι-
Carrageenan forms elastic, dry gels especially in the presence of
calcium salts. The 2-sulfate groups on the outside of the ι-
carrageenan molecule do not allow the helices to aggregate to
the same extent as κ-carrageenan, but form additional bonds
through calcium interactions. Because of the ionic nature of
carrageenan, the gelling and melting temperatures are depend-
ent almost solely on the concentration of the ions and gelation
is strongly influenced by the presence of electrolytes.11 This
hydrophilic polysaccharide forms a gel with potassium and
calcium ions but also shows gelation under salt-free conditions
helped by physical bonds being a thermosensitive hydrogel.12
Thermoreversible gels, such as carrageenan, melt at elevated
temperature and the gelation of the biopolymer is obtained by
lowering the temperature. The temperature-induced gelation
allows for an easy formation of gels with different shapes,
emphasizing the versatility of the carrageenan. Contrary to
carrageenan, alginates are probably the most extensively studied
and characterized hydrogels for cell encapsulation/deliv-
ery.13−15 Besides that, alginate has a similar gelation mechanism
to carrageenan and, thus, in this study we have focused on the
development of hydrogels composed of mixtures of alginate
with different types of carrageenan. The mixture of gelled
hydrocolloids, in this case, alginate and carrageenan, acts
synergistically as a result of the similarity in the type of
polysaccharide gelling mechanism and is expected that
carrageenan favors the final properties of the mixture, providing
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better mechanical properties and tailored degradation profiles.
The gelation reaction is produced when cations diffuse into
hydrocolloid solution and specific segments of the alginate and
carrageenan polymers interact with K+ and Ca2+ ions.16 In this
study, several methodologies were tested to produce a wide
range of systems based on carrageenan−alginate mixtures, with
different properties in terms of biological and mechanical
performance. The processing methodologies used were based
on ionotropic gelation and wet spinning to produce different
formats like beads and polymeric fibers.17,18 The morphology
and structure were analyzed by scanning electron microscopy
(SEM), the size, shape, and membrane thickness were observed
by light microscopy and the mechanical properties of the
obtained hydrogels were evaluated by compression tests.
Furthermore, the effect of several parameters, such as pH and
different ionic compositions of immersion solution, on the in
vitro degradation of the prepared hydrogels was evaluated. The
biocompatibility of the developed systems was assessed by
standard cytotoxicity assays. Chondrocytes were encapsulated
and cultured into the developed beads/fibers and characterized
in terms of cell viability (MTS assay), cell proliferation (DNA
quantification), and histological staining. In summary, the main
goal of this work consisted in the development of an efficient
cell delivery system based on combining properties of two
natural polymers alginate and carrageenan.
■ MATERIALS AND METHODS
Materials. Alginic acid sodium salt from brown algae (71238,
Sigma, U.S.A.), κ-carrageenan (22048, Sigma Fluka, U.S.A.), ι-
carrageenan (22045, Sigma Fluka, U.S.A.), and phosphate buffer
saline (P4417-PBS Sigma, U.S.A.) were used without further
purification. Calcein-AM (acetoxymethyl ester of calcein-C3099) was
purchased from Invitrogen (Portugal).
Development of Alginate−Carrageenan Beads. The hydrogel
beads were obtained based on a droplet technique, which consists of
the extrusion of the liquid polymer from the tip of a capillary tube
continuously until it achieves a critical mass and then detaches and falls
into a receiving solution.19 Alginate and carrageenan aqueous
dispersions were prepared separately by dissolving each of the
biopolymers in distilled water heated up at 50 (for alginate) and 60
°C (for carrageenan) under constant stirring from 30 min to 2 h until
complete dissolution.20 The mixtures/blends composed of 8.0 g
alginate solution and 2.0 g carrageenan solution with concentrations
varying from 2 to 3.5% (blend of alginate with κ-carrageenan are
herein designated by AK and blends of alginate with ι-carrageenan by
AI), were prepared by mixing under constant stirring at 30 °C for 30
min. Previous to use, all solutions were sterilized by steam power
during 30 min at 120 °C. The solutions were prepared just before use
to avoid the initial thermal degradation steps that might affect the
biomaterial response. Briefly, the beads were prepared by dropping the
mixture using a pump (AL-1000, Alladin Programmable Syringe
Pump) from a 5 mL disposable syringe equipped with a needle of 25G
inner diameter into the aqueous salt solutions stirred magnetically.
The precipitating solution was composed of 100 mL of 2% (w/v) KCl
and CaCl2 and the pH of the solution was previously adjusted to 7.4.
After gelation at fixed conditions (30 drops/min, agitation rate 50 rpm,
hardening time 30 min, 25G inner diameter of the needle), the formed
beads were separated, washed, and stored at 4 °C until use. The
compositions of the different formulations studied and the different
parameters used for their preparation are described in Table 1.
Development of Alginate−Carrageenan Fibers. For the
preparation of the polymeric fibers, it was used the same working
solutions as described in the previous section for preparing the beads.
The fibers were obtained by wet spinning, an easy and reproducible
method, which consists in immersing the needle into the cross-linking
solution. Each polysaccharide is ionically cross-linked with the
corresponding cations, thus, alginate and carrageenan prefer to form
a stable gel with Ca2+ and K+, respectively. Alginate−carrageenan fibers
were produced using a coagulation bath of CaCl2·KCl 2%, aiming at
producing 3D fiber meshes. Both κ- and ι-carrageenan can shape
hydrogels with potassium and calcium salts. They have the ability to
form, upon cooling and after addition of the salt, an infinite variety of
gels due to development of double helices of polymeric chains into the
building blocks of a three-dimensional network. The shape and
stability of the hydrogels formed by extrusion techniques are
determined by numerous physicochemical factors. Experimental
conditions were optimized, such as the distance between the syringe
and gelation media, several inner diameters of the needle (21G, 25G,
and 29G), the flow rate of the polymeric solution falling into gelation
bath, the cross-linker concentration, and also the temperature of the
system (Table 1).
Physico-Chemical Characterization of the Developed Hy-
drogels. Morphological Characterization. In this work, the size,
shape, and surface characteristics of the developed hydrogels were
examined using a stereomicroscope (Zeiss, Stemi 1000 PG-HITEC)
and the images were obtained using a camera PowerShot G6, Canon.
Scanning electron microscope (SEM - Leica Cambridge S-360, U.K.)
was used to observe the surface and the cross section morphology of
the hydrogels. For SEM analysis, samples of each condition were
washed in PBS, dehydrated in a gradient series of ethanol solutions,
and allowed to dry completely at room temperature before sputter
coating with gold (Fisons Instruments, Sputter Coater SC502, U.K.).
Degradation Behavior of the Prepared Hydrogels. Degradation
studies were carried out by immersion of the hydrogels discs (Ø 7 ±
0.01 × 10 ± 0.02 mm height, n = 3) in phosphate buffered saline
(PBS, pH 7.4) and culturing medium (DMEM, pH 7.4) at 37 °C. The
hydrogel were lyophilized, weighed (initial weight) before being
transferred to 15 mL Falcon tubes, and soaked in 10 mL of PBS or
DMEM under constant agitation (60 rpm). After each selected
degradation time point (final weight), namely, 1, 7, 14, and 21 days,
the samples were washed thoroughly with PBS to remove traces of
soluble degradation products, salts, or other impurities and then dried
until constant weight was achieved. The degradation solutions were
changed every 7 days to restore the original level of ions activity. At
the end of each degradation period, the dried samples were weighed
Table 1. Conditions Studied Referring to the Alginate−Carrageenan Ratio, Polymeric Concentration, the Salts Used to
Crosslink the Gels and Their Concentration, Different Types of Carrageenan (κ or ι), and Processing Parameters for Obtaining
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for determination of weight loss. The extent of degradation is
commonly determined by calculating the percentage of weight loss (eq
1).
(1)
Mechanical Testing. Uniaxial compression tests were performed to
characterize the mechanical behavior of the produced 2.5% (w/v)
alginate/κ-carrageenan hydrogel discs (Ø 15 ± 0.51 mm × 5.5 ± 0.46
mm height). The hydrogel discs of blends with ι-carrageenan type
were not tested because it was nearly impossible to achieve samples
with precise dimensions and thus difficult to obtain results after
mechanical tests. The tests were carried out at room temperature
conditions using a universal mechanical testing machine (Instron, 4505
Universal Machine). Mechanical testing was performed under
compression using a crosshead speed of 5 mm/min and the results
from tests conducted for at least 10 specimens. The details regarding
these methods are presented elsewhere.21
Cytotoxicity Evaluation. The cytotoxicity of the constituent’s
released from the materials was evaluated using cell culture methods,
namely MEM extraction test (72 h) to select the most promising and
reject any possible systems that are cytotoxic. In all cytotoxicity tests
performed, latex rubber and tissue culture plastic were used as positive
and negative controls, respectively. These assays are particularly aimed
at establishing the possible toxic effects of leachable released from
medical polymers during extraction. The objectives of the MEM
extraction test are to evaluate changes in cell morphology and growth
inhibition, whereas the MTS (3-(4,5-dimethylthiazol-2-yl)-5(3-carbox-
ymethoxyphenyl)-2(4-sulfofenyl)-2H-tetrazolium) assay determines
whether cells are metabolically active.22 The detailed method is
presented elsewhere.23 Briefly, for biocompatibility assessment of the
different formulations of the developed hydrogels a mouse fibroblast-
like cell line, L929 (ECACC- European Collection of Cell Cultures,
U.K.) was used. Cells were fed with Dulbecco’s modified Eagle’s
medium (DMEM, Sigma-Aldrich), supplemented with 10% fetal
bovine serum (FBS, Gibco, U.K.) and 1% antibiotic/antimycotic (A/B,
Gibco, U.K.) solution. L929 cells were incubated at 37 °C in an
atmosphere containing 5% CO2 until 90% confluence was achieved.
Then, a cell suspension with a concentration of 2 × 104 cells/mL
(4000 cells/well) was prepared and seeded onto 96-well plates. Extract
of the developed materials were prepared by incubating the hydrogels
with media containing serum at an extraction ratio of 3 cm2/ml for 24
h at 37 °C. One hundred microliter of the extracts of the hydrogel,
negative control (standard culture medium), and positive control
(latex rubber) were placed on 80% confluent monolayer of cells. The
absorbance of the resulting solution in each well was recorded
immediately at 490 nm using an automated Multi-Mode Microplate
Reader (Synergy HT, Bio-Tek Instruments, U.S.A.). Results were
presented as OD (optical density) after extraction of the blank value
(i.e., medium only) and we conducted all cytotoxicity screening tests
by using six replicates. The results were expressed as percentage of cell
viability calculated using the following equation:
(2)
where OD sample is the optical density obtained in the cells exposed
to each extract and OD control is the OD obtained in the cells
incubated with the culture medium only (negative control).
Encapsulation of ATDC5 Cells into Alginate/Carrageenan
Hydrogels. Cell encapsulation experiments were performed to assess
the viability of cells incorporated in the developed hydrogels and to
further select/optimize the developed formulations as well as the
encapsulation conditions. ATDC5 cells, a cell line established from
chondrocytic cells of a mouse embryonal carcinoma (mouse 129
teratocarcinoma AT805 derived, ECACC, U.K.) was selected for this
work, because these cells are more biologically active in a 3D
environment and have been extensively studied to assess their role in
producing, maintaining, and remodeling the cartilage ECM.24 As
previous experiments revealed that the shape of the hydrogel did not
affect differently the viability or proliferation of the cells, herein it was
decided to present results based on hydrogels with fiber shape. Prior to
cell culture studies, alginate/carrageenan solutions were sterilized by
heat for 30 min at 120 °C. The cells were expanded in cell culture
medium (Ham’s F-12 medium (DMEM-F12, Gibco, U.K.) supple-
mented with 10% FBS (Gibco, U.K.), 2 mM L-glutamine (Sigma), and
1% A/B antibiotic solution (Gibco, U.K.) at 37 °C in CO2 incubator
until obtaining the necessary number of cells for the experiments. After
trypsinization and centrifugation, the cell suspension obtained was
diluted to encapsulate 1 × 106 cell/mL of the polymeric solution to
produce the beads/fibers, as previously described. The beads/fibers
with encapsulated cells were then placed into nonadherent 24-well
plates and maintained in culture for several periods of time (1, 7, 14,
and 21 days) at 37 °C in a CO2 incubator. At the end of each time of
culture, the beads/fibers with the encapsulated cells were retrieved,
washed with PBS solution, and maintained at 4 °C in PBS for further
characterization studies.
Light Optical Microscopy and Fluorescence Staining with
Calcein-AM. ATDC5 cell morphology after encapsulation in beads
and fibers was observed under inverted light microscope (Zeiss,
Axiovert 40 PG-HITEC). The viability of ATDC5 cell line was
investigated using Calcein AM fluorescence labeling after 21 days in
culture. For this assay, the samples were washed with PBS, placed in a
new well plate with 1 mL of DMEM and 2 μL of a calcein-AM solution
(at 1/1000 dilution), and incubated for 15−30 min at 37 °C in 5%
CO2. The fluorescence staining was washed and replaced by 500 μL of
formalin (10%) for 10 min at room temperature to fix the cells.
Afterward, the formalin was removed, and the beads and fibers were
rinsed twice in PBS and observed under a reflected/transmitted light
microscope (Zeiss, Axiocam MRc5).
Assessing the Metabolic Activity (MTS Assay). The alginate−
carrageenan polymers with encapsulated ATDC5 cells were cultured
for 1, 7, 14, and 21 days; cell-free hydrogel samples were kept in the
same conditions to be used as experimental controls. After each of the
selected time points of culture, the medium was removed; samples
were washed with PBS and assessed for their metabolic activity using
the CellTiter 96 Aqueous One Solution Cell Proliferation Assay
(MTS, Promega). Briefly, cell-hydrogel constructs (n = 3) were
washed in PBS and placed in a mixture containing serum-free cell
culture medium DMEM (without phenol red) and MTS reagent at a
5:1 ratio and incubated for 3 h at 37 °C in a humidified atmosphere
containing 5% CO2 at the end of which 100 mL (n = 6) was
transferred to 96-well plates and the OD determined at 490 nm.
Cell Proliferation by DNA Quantification. ATDC5 cell
proliferation in the hydrogels was determined using a fluorimetric
double-strand DNA quantification kit (Quant-iT PicoGreen dsDNA
reagent, Molecular Probes, Invitrogen). For this purpose, samples that
were collected at 1, 7, 14, and 21 days of culturing were transferred
into 1.5 mL microtubes containing 1 mL of ultrapure water. ATDC5
cell-hydrogel constructs and the hydrogel alone (without cells), used
as control, were incubated for 1 h at 37 °C in a water bath, and were
then stored in a −80 °C freezer until they were tested. Prior to dsDNA
quantification, constructs were thawed and sonicated for 15 min.
Samples and standards (ranging from 0 to 2 μg/mL) were prepared
and mixed with a PicoGreen solution in a 200:1 ratio and were placed
on opaque 96-well plate. Each sample or standard was made in
triplicate. The plate was incubated for 10 min in the dark, and
fluorescence was measured on a microplate reader (Synergy HT,
BioTek Instruments) with an excitation of 485/20 nm and an emission
of 528/20 nm. A standard curve was created, and sample DNA values
were read from the standard graph.
Histological Analysis (H&E Staining). Hydrogel fiber samples
were collected at each time point of the study and previously fixed with
10% formalin were processed by a series of dehydration steps,
embedded in paraffin, and sectioned at 4 μm (HM355S Rotary
Microtome, Thermo Scientific). Haematoxylin and eosin (H&E)
staining was conducted in automatic staining equipment (Microm
HMS 740) and then cleared in xylene (VWR) and mounted for further
analysis.
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Statistic Analysis. Data of compression, degradation, MTS, and
DNA assay are presented as means ± standard deviations, with n = 6
for each group. For statistic analysis multiple pair’s comparison has
been performed using One-Way ANOVA, Tukey method with a
significance level of 0.05, using OriginPro 8 program. First an F-test
was used to ascertain about the data normality of the results, namely,
to determine the equality of variance.
■ RESULTS
Development of Carrageenan−Alginate Hydrogel
Beads and Fibers. This study has focused on the develop-
ment of novel hydrogels based on natural-origin polymers,
namely, alginate and carrageenan. To obtain the optimum
hydrogel formulation, several aspects were considered, such as,
the use of different types of carrageenan, ι and κ, different
concentrations of the polymers, and various concentrations of
the salts were evaluated (Table 1). Parameters related to the
processing method, such as flow rate and needle diameter,
show a direct influence in the size of the produced beads;
increasing the flow rate of the polymeric solution resulted in
larger bead diameter and using needles with small diameter
resulted in smaller droplets. The concentration and molecular
structure of carrageenan and alginate, as well as the
concentrations of calcium and potassium chloride, have an
important effect in the gelation process. Other aspects related
to the ionotropic gelation method by droplet formation,
namely, droplet rates, flow rate of the viscous solution,
hardening time, needle distance, needle diameter, and pH of
the solution were taken into account for the optimization of the
gel formation. Contrary to κ-carrageenan, no spherical beads
were formed with formulations based on ι-carrageenan using
the selected salt solutions (Table 1). The optimum
concentration of the reactants was determined using empirically
classical methods. Experiments with κ-carrageenan type showed
that the best bead formation were obtained by dropping 2.5%
κ-carrageenan polymer into 5% potassium chloride solution
while for ι-carrageenan type the best spheres were obtained
with 3.5% dispersion and 2% calcium chloride. Higher
concentrations of the polymer dispersion used in this study
could not be dropped so easily from the needle due to the high
viscosity. The same difficulty was observed with lower
concentrations, which led to unstable gels in terms of shape
and structure. Alginate/κ-carrageenan hydrogel blends were
formed faster than κ-carrageenan alone, due to the quick and
strong reaction of alginate with Ca2+ ions. In addition,
carrageenan basically formed softer beads with less spherical
shape than the alginate-based beads. Alginate/carrageenan
fibers produced by immersion of the polymeric solutions inside
the chemical bath containing potassium and calcium ions
presented the same gelling properties as in the case of beads
formation.
Morphologic Characteristics of Alginate/Carrageenan
Hydrogels. SEM micrographs of the hydrogels, namely, AK
2.5% (Figure 1, A1, beads, and A2, fibers) and AI 3.5% (Figure
1, B1, beads, and B2, fibers) showed no significant differences
regarding the surface morphology. Nevertheless, blends with κ-
carrageenan 2.5% concentration and blends with 3.5%
concentration for the ι-carrageenan type led to the formation
of the most stable and well-defined shapes. From the light
microscopy images of the beads (Figure 1, A1, AK 2.5%, B1, AI
3.5%) and fibers (Figure 1, A2, AK 2.5%, B2, AI 3.5%) in wet
Figure 1. SEM micrographs of alginate−carrageenan blend surface (8:2) of beads A1, AK 2.5%, B1, AI 3.5%, and fibers A2, AK 2.5%, B2, AI 3.5%;
embedded images correspond to light microscopy pictures of the same samples in wet state, precipitated in 2% (w/v) CaCl2·KCl and hardening time
of 30 min.
Biomacromolecules Article
dx.doi.org/10.1021/bm200965x |Biomacromolecules 2011, 12, 3952−39613955
state, one can observe the smooth and homogeneous surface
and the well-defined and stable shapes. The mean beads
dimension for the AK 2.5% (8:2) formulation using 21G needle
was 2.76 ± 0.14 mm, using the 25G diameter needle the mean
dimensions was 2.16 ± 0.13 mm and when applying the needle
of 29G was 1.08 ± 0.07 mm. The mean fiber dimensions for
the AK 2.5% (8:2) formulation were typically lower and
ranging from 1.1 ± 0.08 (21G), 0.9 ± 0.08 (25G), and 0.56 ±
0.08 mm (29G). Various complexes of hydrogels were prepared
from different (5:5 and 8:2) alginate/carrageenan ratios and
variations of carrageenan type, namely, kappa and iota, were
assessed (Figure 2). The hydrogels were cross-linked in
reaction with CaCl2 and KCl and SEM (Scanning Electron
Microscopy) images of cross-linked and noncross-linked
hydrogels were compared. These images show that the pore
size was homogenously distributed and increased with
increasing carrageenan content. More than 60% of the hydrogel
volume or greater, presented porosity, indicating that the
carrageenan content is a key factor for controlling the pore size.
Two different pore morphologies are obvious in the non-cross-
linked, mainly due to the type of carrageenan used, kappa
hydrogels exhibiting round porosity, small and circular cavities,
and iota presenting longitudinal pores and large and elongated
cavities. Regardless of the hydrogel composition, the pore size
(ranging from 100−200 μm) of cross-linked hydrogels was
smaller than the pore size of non-cross-linked ones and many
pores in cross-linked hydrogels were deformed by cross-linking
(Figure 2). The cross-linked hydrogel prepared from an 8:2
alginate/carrageenan mixture using κ-type, followed by reaction
with CaCl2·KCl, enabled the formation of an uniform hydrogel
provided by a good miscibility and, thus, was found to be the
most suitable hydrogels formulation.
In Vitro Degradation Studies. The aim of the degrada-
tion studies was to evaluate the behavior of the developed
materials in simulated physiological conditions. Therefore, the
degradation of the hydrogels was monitored as a function of
incubation time in PBS and DMEM at 37 °C, as shown in
Figure 3. During the degradation time, most of the
formulations based on ι-carrageenan with a low concentration
showed to be very unstable, disintegrating after a few days in
the degradation media, and therefore, only the kappa
formulation was further analyzed. Moreover, it was found that
the hydrogels obtained with higher polymeric concentration
and a polymeric ratio of 8:2 had acceptable stability, and
therefore, these were selected for further and detailed
characterization. The polymeric concentration of the hydrogel
blend had a significant influence on the weight loss. In the first
days of the experiment, the hydrogel blends with lower
Figure 2. Scanning electron microscopy images of freeze-dried cross sections presenting the morphology and porosity of AK 2.5% and AI 2.5%
hydrogel blends (5:5 and 8:2 polymeric ratio, with cross-linking agent and without cross-linking, CaCl2·KCl) at 100× magnifications and 200 μm.
Figure 3. Representation of weight loss percentage vs time of alginate/κ-carrageenan discs with different polymeric concentrations immersed in
culture medium (DMEM) (A) and measurements after immersion in PBS and DMEM solutions at 37 °C for AK 2.5% hydrogel blend (B). Values
reported correspond to averages (n = 3) ± standard deviation.
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concentrations presented the highest weight loss rate. The
hydrogels with 2 and 2.5% polymer concentrations lost about
35−45% of their weight in the first 7 days of the experiment
(Figure 3A). The blended hydrogels with higher concentration
(3 and 3.5%) showed a lower weight loss rate. At day 21, the
AK 2.5% formulation presents the highest weight loss.
Therefore, this formulation was selected for further character-
ization of the degradation behavior and, thus, immersed in PBS
and DMEM medium for up to 21 days. The results obtained
from these experiments are presented in Figure 3B. Weight loss
results showed fast degradation behavior in PBS solution as
compared to DMEM medium.
Mechanical Characterization by Compression Tests.
The mechanical properties of the blend consisting of alginate
and κ-carrageenan 2.5% (w/v, ratio 8:2) were examined in
compression experiments. The Young’s modulus for AK 2.5%
(8:2) in compression was found to be 0.7 ± 0.25 MPa.
Biological Studies: Cytotoxicity Assays. The cytotox-
icity of the components that leach out of the developed
hydrogels was evaluated by a viability assay (the MTS test).
Table 2 shows the results of the cellular metabolic activity
obtained using extracts of the materials under study. The results
obtained revealed that the extracts from the samples with a
higher polymeric concentration did not affect the viability of
the cell line L929. This test demonstrates the extremely low
cytotoxicity levels of the alginate−carrageenan blend when
using higher concentrations of the polymers. On the other
hand, the hydrogels with the lower polymeric concentrations
presented a higher cytotoxicity.
Optical Microscopy and Fluorescence Staining with
Calcein-AM. The cells were encapsulated within the 2.5% (w/
v) alginate/κ-carrageenan hydrogel blend in beads and fibers.
The light microscopic images presenting ATDC5 encapsulated
in beads and fibers show a uniform cell distribution after 21
days in culture, a homogeneous cell density, and smooth, well
delimited shape of the hydrogels. Calcein-AM fluorescence
staining was conducted to assess the ATDC5 cells viability and
distribution within the hydrogels. The majority of the cells were
positive for calcein-AM, which indicates a dominance of viable
cells over a period of 21 days in culture. Three weeks post-
encapsulation, ATDC5 chondrocytes cells exhibited round
shapes, uniform cell distribution into the hydrogel, and a high
cellular density (Figure 4). These results show that both shape
conditions of the hydrogels blend are not cytotoxic and that the
temperature cycle used to promote the sol−gel transition does
not affect cell viability.
Viability and Proliferation of Cells Encapsulated in
the Developed Hydrogels. In this study, the influence of
two parameters on the viability and cell proliferation were
analyzed, namely, the ratio of the two types of carrageenan,
kappa and iota, and also the concentration of the cross-linker
used for the formation of the 3D construct. Generally, from the
MTS and DNA results, it was found that the ATDC5 cells
remain viable and proliferate for up to 21 days of
encapsulation/culture in the 3D hydrogels developed. From
the MTS assay results (Figure 5A), we can observe that the
formulations based on κ-carrageenan enabled higher cell
viability as compared to those based on ι-carrageenan. This
difference in terms of cellular response could be related to the
chemical composition of ι-carrageenan, which presents more
sulphated groups than κ-carrageenan and, thus, the lower
strength of its network,25 enables an easier leach out of cells
from the tested samples. Analyzing the importance of the
polymers ratio used, we can notice an increase in the metabolic
activity obtained for the ATDC5 cells encapsulated in the
formulation with higher alginate content, corresponding to the
ratio 8:2, but not significantly different. For further biological
characterization, it was selected the blend with 2.5% (w/v)
alginate and κ-carrageenan with a ratio of 8:2. The influence of
several concentrations of the reticulation agent (CaCl2·KCl)
and their biological response were investigated (Figure 5B,C).
The results obtained from the MTS assay showed that a lower
concentration of the reticulation agent has a positive effect in
the cellular response especially for AK 2.5% formulation.
Moreover, we can observe a higher cell proliferation with the
formulation exposed to lower concentration of CaCl2·KCl
precipitation bath complementary to the MTS assay results
(Figure 5C)
Histological Analysis (H&E). The morphology of the cells
residing in the hydrogel blends containing one of the two types
of carrageenan and with different polymeric concentration was
further observed by H&E staining. Histological analysis of
samples taken after 21 days of culture was performed using
hematoxylin-eosin (H&E) for regular morphological cellular
analysis (Figure 6). In a typical tissue, nuclei are stained blue,
whereas the cytoplasm and extracellular matrix have varying
degrees of pink staining. From the histological results we
observed that the cells are viable, presenting homogeneous
distribution and exhibit a clearly delimited nucleus over the
culturing period. Encapsulated ATDC5 cells exhibit a normal
morphology, some presenting small nuclei mostly in the initial
culturing period, others large proliferating nuclei by 21 days of
culture and in some cases, one can notice cell clustered
formation in general in kappa condition. Additionally, after
encapsulating ATDC5 chondrocytic cells, we observed that
they were able to proliferate and maintain their typical
chondrocytes morphology, namely, the lacunae aspect.
■ DISCUSSION
Hydrogels can be used for cell delivery,26 as well as growth
factor or drug delivery.27 Hydrogels derived from naturally
occurring polysaccharides mimic many features of extracellular
matrix (ECM) and thus have the potential to direct the
migration, growth and organization of encapsulated and
transplanted cells during tissue regeneration.28 In this study, a
new forming biodegradable hydrogel system was developed,
which may be used as a carrier for cell delivery purpose.
Table 2. Results Obtained from Cytotoxicity Tests
Performed Using Extracts of AK and AI Hydrogels with
Different Concentrationsa
samplesb day 1 day 3 day 7
AK2.5% 74.13 ± 0.72 40.57 ± 2.68 54.39 ± 0.78
AK3% 128.26 ± 6.89 123.00 ± 1.73 98.77 ± 4.88
AK3.5% 106.89 ± 0.62 96.23 ± 3.22 90.26 ± 5.40
AI2.5% 55.99 ± 5.39 28.59 ± 2.03 35.89 ± 0.31
AI3% 91.26 ± 5.50 86.56 ± 2.16 75.24 ± 0.89
AI3.5% 106.89 ± 0.62 96.23 ± 3.22 90.26 ± 5.40
aThe results are based on the MTS test performed after 1, 3, and 7
days of culture. bWe determined the values by taking into account the
fact that TCPs (negative control) corresponded to 100%. Latex was
used as a positive control of cell death and produced cell viability
values that were considered to be negligible.
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Alginate hydrogels are fast gelation systems, hard to control,
often the resulting structure is not uniform and mechanically
strong and thus is difficult to achieve complex-shaped 3-D
structures.29 We expected that adding carrageenan hydrogel to
the system could overcome some of these disadvantages. The
hydrogels were obtained by the cross-linking of alginate and κ-
carrageenan with Ca2+, K+ ions at a stable physiological pH.
Different volume ratios of the hydrogel blend were prepared for
assessing the best formulation in terms of degradation profile,
mechanical stability, and cell behavior. It was possible to
process alginate−carrageenan in different ways, enabling to
obtain various structures/shapes, such as beads and fibers,
which can be used in different approaches/strategies for the
delivery of cells. The smooth appearance of the hydrogels is
clearly observed from the microscopic images of the beads and
fibers in dry and wet state (Figure 1). This demonstrates that
the rigid, glassy alginate polymer can be blended with the highly
flexible, amorphous κ-carrageenan polymer, creating smooth
morphologies and enhance the thermal stability.20,30 The
images obtained from the cross sections of the hydrogels
suggest that the morphology of the blends depends on the type
of carrageenan used, and this may result from the fact that κ-
carrageenan gives harder gels than ι-carrageenan with CaCl2
(The United States Pharmacopeia XXIII, 1995). The SEM
images of the freeze-dried hydrogels also demonstrated that a
higher content of κ-carrageenan results in the formation of
smaller, more round, pores and tighter network structure in the
blend hydrogels (Figure 2). A similar behavior was register in
blends made with carrageenan and gelatin where the average
pore size and porosity decreased with increasing κ-carrageenan
content as well, owing to the high molecular weight and
viscosity of the κ-carrageenan solution.31 Moreover, the
morphology and porosity is highly affected by the gelling
agents, as compared to the degree of cross-linking with ions.
However, our results showed that the type of carrageenan used
in the blend composition and the alginate/carrageenan ratio are
both important parameters for pore size control and shape of
the hydrogel.32 To promote the regeneration of tissues, it is
important that the proposed hydrogels can delivery cells at the
target site but also maintain its structure under physiological
conditions, similar to those found in vivo, for enough time so
that they can perform a protective role for the implanted cells
and thus ensure their functionality.33 In engineered hydrogel
for cell encapsulation/delivery degradation can alter the
diffusion of nutrients, waste, and cell−material interactions.
The performed degradation studies allowed characterizing the
developed hydrogels in simulated physiological conditions like
PBS and DMEM immersion mediums at 37 °C by mimicking
the behavior in the in vivo scenario. As mentioned before, it
was found significant differences and systematic variation in the
formation and stability of the hydrogel, depending on the
polysaccharide used, with κ-carrageenan being firm and rigid
and ι-carrageenan being soft and elastic. Having in mind these
physicochemical differences between κ- and ι-carrageenan type
on the blend formation, only the κ-carrageenan polymer has
been taken into account for degradation characterization. The
hydrogel blend with low concentration revealed less stability,
consequently increasing the exposure of polymer chains to
water molecules and significantly leading to water absorption
enhancement and faster weight loss (Figure 3). Also, the
carrageenan component of blend would be expected to have a
greater preference for water sorption than alginate because of
the presence of highly polar sulfate groups in the structure.30
Polymeric concentration influences many properties of the
resulting hydrogels. In general, an increase in the polymer
concentration results in a decrease in water content and mass
weight loss. In other words, the hydrogels with lower
concentrations present a faster degradation rate, losing almost
Figure 4. Inverted light microscopic images of ATDC5 cell encapsulated in beads and fibers (1A and 1B) and fluorescence staining, calcein-AM
(green, 2A and 2B) images depicting viable cells stained at day 21 of culture.
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45% of their weight by the end of the study. Similar degradation
behavior was found, for example, for hyaluronic acid hydro-
gel.34 The 2.5% alginate−κ-carrageenan hydrogels showed a
slower degradation rate in DMEM medium than hydrogels
exposed to PBS solution at 37 °C (Figure 3). The divalent
cations used to keep hydrogels cross-linked will be exchanged
by monovalent ones, leading to the formation of less cross-
linked networks, as described elsewhere.35 This might be
Figure 5. (A) Metabolic activity of ATDC5 cells encapsulated in the 2.5% alginate−carrageenan with a different polymeric ratio. (B) Hydrogels
exposed to different concentration of the CaCl2·KCl coagulation bath. The results are based on the MTS test performed after 1, 7, 14, and 21 days of
culture. (C) Cell proliferation of ATDC5 cells entrapped in hydrogels blend using the two types of carrageenan with different concentration of the
precipitation bath (CaCl2·KCl). The results are based on the DNA quantification test performed at 7, 14, and 21 days of culture. The symbols *
indicates statistical significance of the formulation AK 2.5% and AI 2.5% (ratio 8:2).
Figure 6. Haematoxylin eosin staining of ATDC5 chondrocytes encapsulated in alginate/κ-carrageenan and alginate/ι-carrageenan type. The
ATDC5 chondrocytes exhibited vacuoles morphology and cell clusters in κ-carrageenan formulation during the experiment, scale bars have 100 μm,
and images are taken at 20× magnification.
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explained further by the higher content of ions in DMEM,
which interact with the hydrogels of ionic nature and also
related to the possible interaction of κ-carrageenan with the
proteins presented in the DMEM medium composition.36
Concerning the mechanical properties it was found that the
mechanical strength of the blends system (alginate/κ-
carrageenan) presented values around 0.7 ± 0.25 MPa.
Interestingly, the mechanical properties exhibited by the
hydrogels in the wet state fall within the normal ranges of
those reported for cartilage native tissue37 and are higher than
the typical values presented for hydrogels like alginate,38
chitosan,39,40 and hyaluronic acid.41 The tensile strength of gels
made from alginates reported in the literature appeared to be
around 150−240 and 250−280 kPa.42 These results clearly
suggest that the compressive modulus of the developed
hydrogels was improved by adding κ-carrageenan to the blends.
It has been reported that the decreased sulfate content of
carrageenan increases the strength of the hydrogel, thus, κ-
carrageenan, which has less-sulfated groups, is expected to have
better properties than ι-carrageenan.25 Another important
aspect for assessing the potential of these hydrogels for
regenerative medicine applications is to evaluate their
biocompatibility and their ability to sustain viability and
proliferation of encapsulated cells. Because the microstructure
and high water content are very similar to that of the
extracellular matrix of natural cartilage, hydrogels are expected
to preserve the viability of the cells. All hydrogels produced
showed a noncytotoxic behavior. Nevertheless, lower polymeric
concentrations and, consequently, less cross-linked networks,
led to lower cell viability results, as a consequence of easier
components release to the extraction medium. With increasing
polymeric concentration the viscosity of the hydrogel also
increases making it more stable when compared with the
formulations with lower concentration, which lose their stability
more easily due to the lower viscosity and cross-linking. Light
and live cell imaging provided a wealth of information about
the biophysics and biochemistry of cells encapsulated in the
hydrogels. Figure 4 presents ATDC5 cells encapsulated in
beads and fibers observed under light and fluorescence
microscopy. Results from samples collected after 3 weeks of
culture showed the presence of viable cells in both hydrogels
formats as indicated by the positive staining with calcein-AM
fluorescent dye. Three formulations (5:5, 7:3, and 8:2)
corresponding to the two types of carrageenan, iota and
kappa, in the blend with alginate were considered for the cell
encapsulation assay. The results showed that the different ratio
of alginate−carrageenan in the blend did not affect significantly
the viability of the encapsulated ATDC5 chondrocytes. From
the data presented in Figure 5A, we can easily observe higher
viability for the formulations with the κ-carrageenan type
compared with the metabolic activity register for the blends
made with ι-type. This cell behavior could be related to the
higher sulfate composition of the ι-carrageenan type.43 The
influence of CaCl2·KCl different concentration over the
metabolic activity and proliferation of ATDC5 encapsulated
cells showed that low concentration have higher cell viability
(Figure 5B). The DNA quantification results complemented
the data obtain from the MTS test (Figure 5C). After
evaluating the influence of the polymeric concentration and
the influence of the cross-linker over ATDC5 chondrocytes
viability, it results clear that the first parameter is more
important compared to the second. HE staining presented
ATDC5 chondrocytes encapsulated within the hydrogel with
typical cartilage spherical morphology (Figure 6), predicting a
potential application of the hydrogel as an injectable scaffold in
cartilage tissue engineering. These results further confirmed the
biocompatibility of the developed hydrogels for cell encapsu-
lation and delivery applications. Evaluation of these properties
contributed to a further understanding of the formation
mechanism of hydrogels and the biological applicability of
these systems. As this process of the blend hydrogel formation
is simple, feasible, and usually performed under mild conditions
without employing any extraneous toxic cross-linking agents,
we believe that such a matrix will have potential applications as
cell delivery systems, wound management, drug delivery,
cartilage tissue engineering, and other related biomedical fields.
■ CONCLUSIONS
We report herein the development of alginate−carrageenan
hydrogels by a mild, friendly technique, yielding on using these
carriers as cell delivery systems. The morphology, degradation,
and mechanical behavior showed highly tunable properties
without affecting their biocompatibility. Finally, the cell
encapsulation assays revealed that alginate/κ-carrageenan
hydrogels presented a positive cellular response, supporting
the viability and proliferation during long-term cell culturing.
The thermo-gelling properties of such materials may also be
used in new injectable systems that could be used to deliver
cells through minimally invasive procedures. In fact, all the
results obtain demonstrated that alginate/κ-carrageenan can be
an innovative and adequate alternative for the development of
carrier systems to encapsulate cells or other bioactive agents of
relevance in tissue engineering applications.
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